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Abstract
Background—Differences in medication use by geographic region may indicate differences in 
access to specialist medical care, especially in the case of prescriptions for psychotropic 
medications. We assessed the effect of more or less urbanized residence on likelihood of 
psychotropic medication use in a large cohort of older adults in Pennsylvania, USA.
Methods—Community-dwelling older adults were recruited from senior centers across PA. 
Participant residences were geocoded and categorized according to U.S. Department of 
Agriculture Rural-Urban Continuum Codes. We used the codes to identify respondents who live in 
relatively urban counties with 250,000 or more residents (n=1360) or less urban counties with 
fewer than 250,000 residents (n=401). Participants reported prescription medications in a clinical 
interview. Psychotropic medications were categorized by class. Logistic regression models were 
estimated to assess the independent effect of residence on likelihood of psychotropic medication 
use.
Results—Geographic region was significantly associated with use of psychotropic medications. 
Psychotropic medication use was higher in less urban areas (19.7%) relative to more urban areas 
(14.2%), p =.007. In adjusted models, degree of urban residence was a significant correlate in 
models that adjusted for sociodemographic features and medical status (odds ratio, 1.62; 95% 
confidence interval 1.13–2.31, p < .01). Use of psychotropic medications on the Beers list also 
increased with less urban residence (13.0% vs. 8.3%, p = .005).
Conclusions—Older adults living in less urbanized areas are more likely to be prescribed 
psychotropic drugs. This difference may indicate a health disparity based on access to geriatric 
specialists or mental health care.
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Prescriptions for psychotropic medications are common among older adults. A large Danish 
study showed that older age was associated with a higher probability of long-acting 
benzodiazepines use as well as use of three or more psychotropic drugs.[1] According to a 
Finnish study, two out of three community-dwelling older adults are prescribed at least one 
CNS medicine.[2] In the United States, nearly one in five community-dwelling elderly use 
psychotropic medications, primarily antidepressants followed by anti-anxiety agents.[3] 
Although psychotropic medications may help in the management of mental health 
conditions in older adults, the medications also carry risks for deleterious effects. For 
example, use of sedatives, hypnotics, antidepressants, and benzodiazepines may be 
associated with falls.[4] Adverse effects of anxiolytic and tricyclic medications may include 
psychomotor retardation, postural hypotension, and anticholinergic effects, which may cause 
blurred vision and cognitive impairment.[5]
Epidemiologic studies suggest that psychotropic medication use is more common in whites,
[6] women,[3,7] and individuals who report poorer health.[3] In this research we ask if 
location, in particular degree of urban residential status, may also play a role in prescribing 
patterns for psychotropic medications.
In the United States, access to medical services varies by place. Geriatric and mental health 
services are less available in rural areas.[8–10] For example, the number of geriatricians per 
10,000 older adults is lower in rural areas (from 1.48 in the most urban areas to 0.80 in the 
most rural). Similarly, board-certified internal medicine physicians are more plentiful in 
urban counties and not as accessible in less urban areas (27.29 vs. 3.85 per 10,000 older 
adults). The presence of family physicians varies less across the rural-urban continuum 
(ranging from 22.02 to 14.27 per 10,000 older adults) but still suggests less access to 
medical care in the rural sector.
Variation in psychotropic medication use may also reflect differences between older adults 
living in more and less urban areas, such as differences in medical status or 
sociodemographic features, or perhaps differences in the kinds of psychotropic medications 
prescribed. This research sought to determine (i) if differences in psychotropic medication 
use were evident across the more urban-less urban continuum, (ii) whether differences in 
psychotropic medication use persist in analyses that adjust for potential differences between 
more and less urban populations, and (iii) whether these differences were apparent for all 
classes of psychotropic drugs or only particular classes.
Methods
In 2010–2011 we enrolled a large group of community-dwelling seniors in Falls-Free PA, a 
research study comparing falls incidence among older adults completing Pennsylvania’s 
Healthy Steps for Older Adults, a falls prevention program (n=814), and a comparator group 
of older adults from the same senior services sites who did not complete the program 
(n=1015). Both groups completed baseline interviews by telephone after providing informed 
consent, and all were followed up to a year in monthly automated or in-person telephone 
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interviews to track falls. Exclusion criteria included inability to provide informed consent, 
language other than English or Spanish, and inability to participate in telephone follow-up; 
otherwise all seniors attending PA Department of Aging programs were eligible.
Details of recruitment and follow-up for Falls-Free PA are reported elsewhere.[11] Briefly, 
the Falls Free-PA study enrolled participants in 19 counties. A total of 2459 older adults 
were ascertained at Healthy Steps senior center sites and agreed to give contact information 
to the research team. 90.5% (n=2219) signed informed consent, and 1835 subsequently 
completed baseline assessment and were eligible for follow-up. We excluded 74 participants 
who did not provide medication information or addresses that could be geocoded. A total of 
1761 were included in analyses. The University of Pittsburgh Institutional Review Board 
approved the research.
Geocoding and Classification by Rural-Urban Status
The Rural-Urban Continuum Codes used in this paper are based on a methodology 
developed by the Economic Research Service of the US Department of Agriculture (USDA).
[12] The rural-urban classification scheme distinguishes metropolitan counties by population 
size and nonmetropolitan counties by degree of urbanization and adjacency to a 
metropolitan area. Each county in the U.S. is assigned to one of nine categories. This 
detailed residential classification permits researchers to analyze patterns that may be related 
to degree of residential density and proximity to more populous areas.
While nine categories are available in the USDA classification, the Falls Free-PA sample 
was limited to residents mostly in the four most populous categories. The final distribution 
of participants included the following: Highly Urbanized County, “county in metro area with 
1 million or more” (n=872); Urbanized County, “county in metro area of 250,000 to 1 
million” (n=488); Less Urbanized County, “county in metro area of fewer than 250,000” 
(n=207); and Rural County, “non-metro county with urban population 20,000 or more, 
adjacent to metro area” (n=194). For analyses, we dichotomized the sample to define more 
urban (counties with 250,000 or more residents, n =1360, “highly urbanized” or 
“urbanized”) and less urban (counties with fewer than 250,000 residents, n=401, “less 
urbanized” or “rural”) regions.
Measures
Respondents reported birth date, race-ethnicity, gender, education, marital status, living 
arrangement, and adequacy of monthly income. To elicit medical conditions, respondents 
were asked if a physician had ever diagnosed any of the following: stroke, diabetes, high 
blood pressure, heart attack, macular degeneration, arthritis, osteoporosis, glaucoma, 
depression, chronic obstructive pulmonary disease, congestive heart failure, neuropathy, 
Parkinson’s disease, cognitive impairment, fractures, or cancer.
To elicit prescription medications, respondents were asked to gather all prescription 
medications and reported names of medications and daily regimens of use. We calculated 
the total number of prescription medications each respondent reported. Psychotropic 
medications mentioned by respondents were coded as antidepressant, anxiolytic, sedative-
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hypnotic, or antipsychotic, as categorized by a clinical pharmacist. Thirty-five medications 
were assigned to psychotropic medication classes as shown in the Appendix.
Analyses
Descriptive statistics were calculated for the Falls Free-PA sample by geographic residential 
category. Participants in geographic groups were compared according to sociodemographic 
factors, prevalence of medical conditions, and use of psychotropic medications using t-tests 
to assess differences in means for continuous variables and χ2 for differences in proportions. 
Logistic regression models were estimated to assess the effect of urban residence on 
likelihood of psychotropic medication use adjusting for other potential correlates of 
psychotropic use. Coefficients from the logistic regression models were exponentiated to 
give the change in the odds of psychotropic use for a one unit increase in each correlate 
independent of the effect of other correlates.
Results
Participants in Falls-Free PA were mostly white (88.2%) and female (79.2%), with a mean 
age (sd) of 75.5 (8.4) years. 38.6% of the sample reported education beyond high school, 
mostly 1–2 years of college or trade school. About half the sample reported solo residence. 
22.8% of the sample resided in less urban areas, defined as counties with less than 250,000 
residents. The mean number (sd) of prescriptions among respondents was 3.7 (3.0). A third 
reported five or more prescription medications.
To assess potential selection bias in the final analytic sample, we compared respondents who 
reported prescription drug information to the 4% of the sample who refused or did not 
supply information for other reasons (Table 1). Participants who declined or were unable to 
provide prescription drug information were older (77.7 vs. 74.9, p = .006) and less likely to 
have post-high school education (23.3% vs. 39.2%, p = .006). While minorities were 
overrepresented among participants not providing drug information, differences did not 
achieve significance. Level of urban residence was not associated with willingness to 
provide prescription drug information.
Comparison of Older Adults by Urban Residence
Sociodemographic characteristics were associated with urban status (Table 2). Respondents 
living in more urban counties were more likely to be female (80.4% vs. 74.3%, p = .008), 
more likely to report minority status (African-American, 10.2% vs. 1.8%, p < .001; Latino, 
3.4% vs. 0.7%, p = .005), and more likely to have post-high school education (43.4% vs. 
24.9%, p < .001). Residents of more and less urbanized areas did not significantly differ in 
reported difficulty with self-care activities (more urban, 5.9%; less urban, 6.2%, p = .18) or 
household maintenance tasks (more urban, 26.5%; less urban, 30.7%, p = .26).
Urban status was not associated with the prevalence of self-reported medical conditions 
except diabetes (30.2% in less urban vs. 22.6% in more urban counties, p=.002). The groups 
were similar in the proportion reporting stroke, hypertension, myocardial infarction, macular 
degeneration, arthritis, osteoarthritis, glaucoma, history of depression or anxiety, chronic 
obstructive pulmonary disease, congestive heart failure, peripheral neuropathy, Parkinson’s 
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disease, and cancer. Residents of more urban counties did not significantly differ in a count 
of medical conditions (2.8 in more urban, 2.9 in less urban). The proportion of older adults 
using at least one prescription medication also did not differ by region: 92.6% in more urban 
areas, 92.3% in less urban areas. The mean (sd) number of prescription medications was 
marginally higher among less urban residents: 4.0 (3.2) vs. 3.7 (2.9), p = .049.
Use of Psychotropic Medications by Urban Residence
In this statewide sample of older people using senior center services, 15.4% reported current 
use of at least one psychotropic medication (see Appendix for medications). By class, 11.4% 
reported use of an antidepressant, 5.1% an anxiolytic, 0.9% a sedative-hypnotic, and 0.7% 
an antipsychotic (Table 3).
Urban status was associated with use of psychotropic medications (Table 3). In less urban 
areas, 19.7% reported a psychotropic medication compared to 14.2% in more urban areas (p 
= .007). Using the full range of USDA rural-urban continuum codes, psychotropic 
medications were reported by 13.3% of seniors in highly urbanized counties, 15.8% in 
urbanized counties, 17.4% in less urbanized counties, and 22.2% in least urbanized counties 
(p=.015).
Differences in Psychotropic Medication Prescription by Urban Residence: Multivariable 
Models
To assess the independent effect of urban status on likelihood of psychotropic medication 
use, we estimated a series of logistic regression models to adjust for the effects of potentially 
confounding variables (Table 4). Models included sociodemographic indicators and two 
approaches to disease conditions. Models 1 and 2 included history of depression or anxiety 
because of the strong association between these mental health conditions and use of 
psychotropic medication. Model 3 included a count of all reported disease conditions. We 
also varied urban residence status. Model 1 included the dichotomous indicator, and models 
2 and 3 the four-level continuum indicator.
In logistic regression models, women were significantly more likely to report psychotropic 
medication use (OR=2.43–2.66, p < .001). Older age and living alone were independently 
associated with lower risk of psychotropic drug use, which achieved significance in models 
that included a count of medical conditions. Marital status and years of education were not 
significant as correlates of psychotropic use, and living alone was a significant correlate 
only in one of the three models. Strong associations were evident for medical correlates, 
most notably history of depression and anxiety. The very high odds ratios suggest that this 
measure identified a subset of respondents with current treatment for psychiatric conditions. 
For each additional medical condition reported, respondents were about 20% more likely to 
report use of a psychotropic medication (Model 3).
Urban residence status was a significant correlate of psychotropic drug use in each of the 
multivariate models. Using the dichotomous measure in Model 1, older adults living in 
counties with less than 250,000 people were significantly more likely to report psychotropic 
medications (OR=1.62, 95% CI: 1.13, 2.31, p < .01) after adjustment for sociodemographic 
factors and presence of reported mental health conditions. Model 2 included the full 
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continuum of more urban-less urban residence and showed that this effect is driven mostly 
by greater use of psychotropic medications in people at the least urbanized end of the 
continuum. Odds ratios were higher in “less urbanized counties” (county in metro area of 
fewer than 250,000; OR 1.56 [0.95, 2.55]) and in “rural counties” (non-metro county with 
urban population 20,000 or more, adjacent to metro area; OR 1.68 [1.03, 2.72], p < .037). 
The significance of residing in the least urbanized areas was confirmed in Model 3, which 
adjusted for the number of reported disease conditions.
Differences between More and Less Urbanized Areas by Class of Psychotropic Medication
By drug class, older adults in more and less urban areas differed significantly only in use of 
anxiolytics (7.0% vs. 4.5%, respectively, p = .045) (Table 3). Overall, 2.5% of respondents 
reported prescriptions in more than one class of psychotropic medication, which did not 
differ by location.
As shown in the Appendix, 26 of the 35 medications tracked in this study appear on the 
2012 Beers list as potentially inappropriate medications for patients aged 65 years or older.
[13] More and less urbanized residents differed in the proportion with a psychotropic 
medication on the Beers list. Among residents in more urban counties, 8.3% reported a 
psychotropic medication on the Beers list compared to 13.0% among less urban residents (p 
= .005). Prescriptions for psychotropic medications on the Beers list increased across the 
more urban-less urban continuum: 8.1% in highly urbanized counties, 8.6% in urbanized 
counties, 9.7% in less urbanized counties, and 16.5% in least urbanized counties (p = .004).
Discussion
In this sample of older adults ascertained in senior centers, prescriptions for psychotropic 
medication prescriptions ranged from 13.3% in the most highly urbanized counties to 22.2% 
in less urban areas. Using the threshold of 250,000 people to separate counties, we found 
that 19.7% of older adults in less urban areas reported a psychotropic medication compared 
to 14.2% in more urban areas. These figures are in accord with findings from other studies.
[3] Despite growing awareness of the potential risks of psychotropic medication use, about 
one in five older adults in less urban areas receive prescriptions for these classes of 
medication.
We found that gender, age, and medical conditions, both psychiatric conditions and total 
count, were associated with use of psychotropic medications. Consistent with other studies, 
women were twice as likely to report use of the medications.[3] Participants under age 75 
were more likely to report use of psychotropic medications than people over age 75. This 
finding contradicts findings of Nordic studies showing that older age is associated with 
greater use of benzodiazepines, antidepressants, anxiolytics, antipsychotics, and hypnotics.
[14, 15] A possible reason for these differences may be sources of data. The Nordic studies 
relied on administrative pharmacy claims, while medication information in the Falls Free-
PA sample was established in an interview.
After controlling for sociodemographic and disease status measures, urban residence was 
still significantly associated with use of psychotropic medications. Residents of less urban 
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counties were nearly twice as likely to report use compared to more urban counties. We did 
not find as strong a trend for polypharmacy. As noted earlier, the mean number of 
prescription medications was only marginally higher among less urban residents: 4.0 vs. 3.7.
Possible explanations for the greater use of psychotropic medications in less urban areas 
include less access to geriatricians, psychiatrists, and mental health care specialists 
generally.[10,16] In less urban settings, family physicians and general internists are more 
likely to address mental health among older adults than specialists.[9] One study found that 
medical generalists score lower than geriatricians on appropriate prescribing and proactive 
assessments for geriatric and psychological syndromes, which may help explain the greater 
rates of psychotropic medication prescriptions in these areas.[17] More generally, medical 
generalists are unlikely to receive geriatrics training.[18] Recognizing this problem, 
interventions have been developed to help lower inappropriate prescribing for older adults.
[19]
Limitations of our study should be noted. The use of a senior center sample does not allow 
us to generalize results to older adults as a whole, nor does it provide an accurate 
representation of the entire older U.S. population. Importantly, the Falls Free-PA sample 
does not adequately represent the most rural localities. We relied on participants’ self-
reports on prescription medications and co-morbidity, which might be less accurate than 
collecting pharmacy claims or other data from participants’ medical files. Finally, we were 
unable to collect information on sources of medical care, and, most critically, who 
prescribed psychotropic medications.
Conclusions
This study confirms the high prevalence of psychotropic medication use, with less urban 
residence as a risk factor for psychotropic medication use. Our findings highlight the need 
for a proactive approach that involves assessment of the appropriateness of psychotropic 
medications. Findings regarding psychotropic medications in this sample raise two key 
concerns. First, while 15.4% of respondents were taking a psychotropic medication, 2.5% 
were taking medications involving two or more classes of psychotropic medication. Use of 
multiple classes of psychotropic drugs is a concern, since the effectiveness of combining 
different types of psychotropic medications is questionable.[20] Second, of the 35 
medications tracked in this study, 26 appear on the 2012 Beers list as potentially 
inappropriate medications for patients aged 65 years or older (Appendix),[13] and less 
urbanized residence was associated with greater use of these Beers-list medications. Our 
results suggest that residents of less urbanized may be at higher risk for potentially 
inappropriate prescribing of psychotropic medications.
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Name (Generic/Brand) Beers Antidepressant Anxiolytic Sedative-Hypnotic Antipsychotic
Amitriptyline (Elavil) X X
Bupropion (Wellbutrin) X X
Citalopram (Celexa) X X
Desvenlafaxine (Pristiq) X
Doxepin (Sinequan) X X
Duloxetine (Cymbalta) X
Escitalopram (Lexapro) X
Fluoxetine (Prozac) X X
Mirtazepine (Remeron) X X
Nortriptyline (Pamelor) X X
Paroxetine (Paxil) X X




Alprazolam (Xanax) X X
Buspirone (Buspar) X
Clonazepam (Klonopin) X X
Clorazepate (Tranxene) X X
Diazepam (Valium) X X
Lorazepam (Ativan) X X
Oxazepam (Serax) X X
Temazepam (Restoril) X X
Eszopiclone (Lunesta) X
Zolpidem (Ambien) X X
Aripiprazole (Abilify) X X
Asenapine (Safris) X X
Fluphenazine (Prolixin) X X
Haloperidol (Haldol) X X
Lithium (Eskalith, Lithobid) X
Olanzepine (Zyprexa) X X
Perphenazine (Trilafon) X X
Quetiapine (Seroquel) X X
Risperidone (Risperdal) X X
Ziprasidone (Geodon) X X
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Table 1
Falls Free, PA: Features of Respondents According to Availability of Prescription Information
Provided Information on 
Prescription Medications (n = 
1761)
Did Not Provide Information (n = 
74) p
Age, mean (sd) 74.9 (8.4) 77.7 (9.8) .006
Women, % 79 82.4 .48
Widow, % 44.1 51.4 .22
African-American, % 8.3 15.5 .23
Latino, % 2.8 5.4 .19
Any post-HS education, % 39.2 23.3 .006
Living alone, % 52.8 60.8 .38
Residence in more rural region (counties with < 
250,000 people)
22.8 23.4 .48
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Table 2
Falls Free, PA: Sociodemographic Status by Region
Descriptive County Population 250,000 or more (n = 1360) County population Less than 250,000 (n = 401) p
Age, Mean (sd) 75.0 (8.3) 74.5 (8.7) .30
Women, % 80.4 74.3 .008
Widow, % 44.2 43.8 .88
African-American, % 10.2 1.8 < .001
Latino, % 3.4 0.7 .005
Any post-HS education, % 43.4 24.9 < .001
Living alone, % 53.8 49.4 .29
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Table 3
Falls Free, PA: Medication Use by Region
Descriptive County Population 250,000 or more (n = 1360) County population Less than 250,000 (n = 401) p
Any Psychotropic, % 14.2 19.7 .007
Psychotropic Class, %
 Antidepressant 10.9 13.2 .20
 Anxiolytic 4.5 7.0 .045
 Antipsychotic 0.8 0.5 .52
 Sedative-Hypnotic 0.7 1.2 .33
Note: 2.5% of respondents reported medication in more than one class; hence classes do not sum to percentages indicated by “any psychotropic.”
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Table 4
Falls Free, PA: Correlates of Psychotropic Medication Use
Model 1 Model 2 Model 3
OR (95% CI) OR (95% CI) OR (95% CI)
Gender
 Male 1.0 1.0 1.0
 Female 2.66 (1.68, 4.20)*** 2.66 (1.68, 4.20)*** 2.43 (1.56, 3.78)***
Marital Status
 Married or other status 1.0 1.0 1.0
 Widowed 0.97 (0.67, 1.42) 0.98 (0.67, 1.43) 0.75 (0.53, 1.06)
Education
 Up to 12 years 1.0 1.0 1.0
 Higher education 0.85 (0.61, 1.18) 0.85 (.0.61, 1.18) 0.75 (0.55, 1.01)
Age
 75 years or less 1.0 1.0 1.0
 76 years or more 0.78 (0.56, 1.09) 0.78 (0.56, 1.10) 0.58 (0.43, 0.79)***
Live alone
 No 1.0 1.0 1.0
 Yes 0.87 (0.61, 1.23) 0.87 (0.61, 1.23) 0.61 (0.44, 0.85)**
History, Depression or Anxiety
 No 1.0 1.0
 Yes 17.6 (12.8, 24.2)*** 17.6 (12.7, 24.2)***
Region
 ≥250,000, More Urban 1.0
 < 250,000, Less urban 1.62 (1.13, 2.31)**
Count of Medical Conditions 1.20 (1.10, 1.30)***
Region
 Highly Urbanized 1.0 1.0
 Urbanized 0.99 (0.69, 1.45) 1.13 (0.81, 1.59)
 Less Urbanized 1.56 (0.95, 2.55) 1.41 (0.91, 2.19)
 Rural, Least Urbanized 1.68 (1.03, 2.72)* 1.70 (1.09, 2.64)*
Model Fit, χ2, df 424.7, 7, p < .001 424.8, 9, p < .001 70.1, 9, p < .001
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